Clinical trials recruiting in Oulu, Finland

Phase breakdown

Conditions recruiting in Oulu, Finland

Recruiting trials in Oulu, Finland

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
  NCT06966700 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
  NCT07076407 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female)
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT06667076 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
  NCT06077760 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
  NCT07438496 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  NCT06623422 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
  NCT06841354 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
  NCT07502560 · Phase: Phase 4 · Ages: 76 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
  NCT06976203 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female)
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  NCT06629779 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07188805 · Phase: Phase 3 · Ages: 6 Months to 17 Years · Sex: All (male and female)
• Adolescent Interpersonal Counseling in Primary Care
  NCT06390462 · Phase: Not specified · Ages: 13 Years to 16 Years · Sex: All (male and female)
• Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
  NCT06282952 · Phase: Not applicable (e.g. observational or device study) · Ages: 0 Hours to 6 Hours · Sex: All (male and female)
• Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer
  NCT07331519 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 74 Years · Sex: All (male and female)
• Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation
  NCT03642509 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06966401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06963021 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
  NCT06328361 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Open-label Extension Study in Participants With Early Alzheimer's Disease
  NCT07105709 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female)
• PEPPI Study: Identification of Women at Risk for Placental Dysfunction
  NCT06115122 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
  NCT04731558 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
  NCT05245877 · Phase: Phase 4 · Ages: 18 Years to 120 Years · Sex: All (male and female)
• Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation
  NCT06696079 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Robotic Versus Laparoscopic Surgery for Deep Endometriosis
  NCT05179109 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
  NCT06697301 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Strengthening Healthy Emotional Co-regulation of Mothers With PCOS and Obesity and Their Infants
  NCT07129434 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female
• Supporting Lifestyle Changes After Delivery
  NCT06241144 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Virtual Reality in Rehabilitation of Executive Functions in Children With Attention Deficit Hyperactivity Disorder.
  NCT06123741 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 12 Years · Sex: All (male and female)
• Virtual vs. Traditional CPR Training: Effects on Stress
  NCT07147322 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 30 Years · Sex: All (male and female)
• Youth Experiences and Health Study
  NCT03332966 · Phase: Not specified · Ages: 15 Years to 18 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Oulu, Finland?

33 recruiting trials have at least one study site in Oulu, Finland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.